Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 71335-0244

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 71335-0244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350244)

Label Image (Lbl713350244)
This is a medication description for Rabeprazole, a blue round tablet with KU;7 on one side and Sod. DR20mg on the other side. It is a generic equivalent of Aciphex 20mg Tablet, made by Lannett Company. The medication should be stored at room temperature between 20°-25°C (68°-77°F) and kept out of reach of children. The expiration date is not available. The text includes a label with the National Drug Code (NDC) number 7133502441 027331523487.*
FDA Label Image

Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)

FDA Label Image

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)
This is a report of a study that includes three groups of participants. The first group, called "PLACEBO," consists of 68 individuals. The second group, "RAB 10mg," has 64 participants, and the last group, "RAB20mg," includes 67 individuals. The study took place across four weeks, labeled as study day 0, 7, 14, 21, and 28. The study measured heartburn scores on a scale of 0 to 4, with 0 being no heartburn and 4 being very severe heartburn.*
FDA Label Image

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)
This text contains data on the number of participants in a study who were given either a placebo or varying doses of a drug called RAB. There were 68 people in the placebo group, 64 in the group given 10mg of RAB, and 67 in the group given 20mg of RAB.*
FDA Label Image

Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)

FDA Label Image

Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.